Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.
about
Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-AnalysisDifferent immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy.Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged miceA novel mouse model of thromboembolic stroke.Translational Stroke Research on Blood-Brain Barrier Damage: Challenges, Perspectives, and Goals.Partial MHC Constructs Treat Thromboembolic Ischemic Stroke Characterized by Early Immune ExpansionDRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury.Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.Partial MHC class II constructs as novel immunomodulatory therapy for stroke.Regulatory T Cell Therapy for Ischemic Stroke: how far from Clinical Translation?Recent Advances in Stem Cell-Based Therapeutics for Stroke.DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury.A Post-stroke Therapeutic Regimen with Omega-3 Polyunsaturated Fatty Acids that Promotes White Matter Integrity and Beneficial Microglial Responses after Cerebral Ischemia.cPKCγ-Modulated Autophagy in Neurons Alleviates Ischemic Injury in Brain of Mice with Ischemic Stroke Through Akt-mTOR Pathway.Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
P2860
Q28552445-134B8C50-C80C-4B35-A7E6-1FFCD7382957Q34242088-00572063-7B71-4960-B3F4-F995978C4F05Q35071226-B713F1FE-7099-4401-8487-5683341C8545Q35781185-D67D72E5-8FAD-489E-A8F1-872CEA938034Q36731242-4BBF663C-67BC-4AEA-9BBB-B3161C7EF21DQ36790648-8D7A6E71-F508-4083-B604-94F6A37BD04CQ38743804-B4D89983-1640-4EC9-BC7B-F5543A107CDFQ38791052-E44DACBE-1C43-46AA-A311-EA16939A774FQ38988985-16B55BB6-F0F5-414E-9CDB-A1E11F218E79Q41658163-3864C0FD-6773-44E1-8001-D2529B28EC50Q44836823-13CA4834-5686-4F28-94A8-E950EB84D22BQ48011437-28FC8D35-05C6-4F14-AD19-4DA8BE281129Q48039676-A3F79A5B-4959-450B-BB54-1CCC417CCDFFQ48578193-D7D2AE9D-938D-44A1-82C5-D11CA28B631DQ50203349-851B932D-7D64-4948-B96E-33934C99BDAD
P2860
Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Recombinant T cell receptor li ...... experimental ischemic stroke.
@ast
Recombinant T cell receptor li ...... experimental ischemic stroke.
@en
Recombinant T cell receptor li ...... experimental ischemic stroke.
@nl
type
label
Recombinant T cell receptor li ...... experimental ischemic stroke.
@ast
Recombinant T cell receptor li ...... experimental ischemic stroke.
@en
Recombinant T cell receptor li ...... experimental ischemic stroke.
@nl
prefLabel
Recombinant T cell receptor li ...... experimental ischemic stroke.
@ast
Recombinant T cell receptor li ...... experimental ischemic stroke.
@en
Recombinant T cell receptor li ...... experimental ischemic stroke.
@nl
P2093
P2860
P1476
Recombinant T cell receptor li ...... experimental ischemic stroke.
@en
P2093
Amanda Casper
Halina Offner
Nabil J Alkayed
Nicole L Libal
Sheetal Bodhankar
Wenbin Zhu
P2860
P2888
P304
P356
10.1007/S12975-014-0348-8
P577
2014-06-24T00:00:00Z
P5875
P6179
1024177356